Chemed Co. (NYSE:CHE) Shares Acquired by Bokf Na

BOKF NA grew its position in Chemed Co. (NYSE:CHE - Free Report) by 52.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,536 shares of the company's stock after buying an additional 872 shares during the period. BOKF NA's holdings in Chemed were worth $1,323,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. UMB Bank n.a. boosted its position in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares during the period. Atala Financial Inc acquired a new position in Chemed in the 4th quarter valued at about $29,000. CBIZ Investment Advisory Services LLC grew its position in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares in the last quarter. Trust Co. of Vermont acquired a new position in Chemed in the 4th quarter valued at about $34,000. Finally, Tortoise Investment Management LLC grew its position in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Activity

In other news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total value of $866,790.00. Following the completion of the sale, the executive vice president now owns 16,127 shares of the company's stock, valued at $9,319,148.22. This represents a 8.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at $60,957,441.93. This trade represents a 1.91% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,000 shares of company stock worth $3,534,135 over the last 90 days. 3.29% of the stock is currently owned by corporate insiders.

Chemed Trading Down 0.2%

NYSE:CHE traded down $1.15 during trading hours on Wednesday, hitting $556.02. The company's stock had a trading volume of 58,296 shares, compared to its average volume of 100,509. The stock has a market capitalization of $8.13 billion, a P/E ratio of 28.10, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61. The stock has a fifty day moving average of $588.00 and a 200-day moving average of $564.58.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same period in the prior year, the company posted $5.20 earnings per share. The firm's revenue for the quarter was up 9.8% on a year-over-year basis. On average, sell-side analysts forecast that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio is currently 9.74%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on CHE shares. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada lifted their price objective on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.